Search results for "Subtype"

showing 10 items of 117 documents

Predictive factors of severe multilobar pneumonia and shock in patients with influenza

2014

PurposeTo identify risk factors present at admission in adult patients hospitalised due to influenza virus infection during the 2009/10 and 2010/11 seasons—including whether infection was from pandemic or seasonal influenza A infections—that were associated with the likelihood of developing severe pneumonia with multilobar involvement and shock.MethodsProspective cohort study. Patients hospitalised due to influenza virus infection were recruited. We collected information on sociodemographic characteristics, pre-existing medical conditions, vaccinations, toxic habits, previous medications, exposure to social environments, and EuroQoL-5D (EQ-5D). Severe pneumonia with multilobar involvement a…

AdultMalemedicine.medical_specialtyHealth StatusClinical prediction ruleComorbidityCritical Care and Intensive Care MedicineLogistic regressionInfluenza A Virus H1N1 SubtypeAltered Mental StatusPredictive Value of TestsRisk FactorsInternal medicinePandemicInfluenza HumanmedicineHumansProspective StudiesIntensive care medicineProspective cohort studyAgedbusiness.industryShockGeneral MedicinePneumoniaMiddle Agedmedicine.diseaseComorbidityVaccinationPneumoniaSpainArea Under CurveMultivariate AnalysisEmergency MedicineFemalebusiness
researchProduct

Synchronous parenchymal renal tumors of different histology in the same kidney

2009

Background: Synchronous primary cortical tumors of different histology in the same kidney are rare. Preoperative awareness of this coexistence is important, since it can help in planning the surgical approach. Purpose: To describe the imaging findings observed in five patients with two parenchymal malignant tumors of different histology in the same kidney. Material and Methods: We reviewed the pathology reports of 381 patients operated for renal tumors from January 2000 to March 2007. The medical records of all patients with multiple, synchronous, primary lesions of different histology in the same kidney were reviewed with special attention to imaging findings and indications on the nature…

AdultMalemedicine.medical_specialtyPathologyContrast MediaRenal tumorImagingDifferent subtypeNeoplasms Multiple PrimaryRetrospective StudieParenchymaCarcinomamedicineHumansRadiology Nuclear Medicine and imagingCarcinoma Renal CellRetrospective StudiesAgedAged 80 and overKidneyRadiological and Ultrasound Technologybusiness.industryMedical recordMultifocalityKidney NeoplasmHistologyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseKidney NeoplasmsCarcinoma Papillarymedicine.anatomical_structureAdenocarcinomaFemaleRadiologybusinessTomography X-Ray ComputedKidney diseaseAdenocarcinoma Clear CellHuman
researchProduct

Incidence of Narcolepsy in Germany

2015

Study objectives Following the 2009 pandemic, reports of an association between an AS03 adjuvanted H1N1 pandemic influenza vaccine and narcolepsy were published. Besides determining background incidence rates for narcolepsy in Germany this study aimed at investigating whether there was a change in incidence rates of narcolepsy between the pre-pandemic, pandemic, and the post-pandemic period on the population level. Design Retrospective epidemiological study on the incidence of narcolepsy with additional capture-recapture analysis. Setting German sleep centers. Patients or participants Eligible were patients with an initial diagnosis of narcolepsy (ICD10 Code G47.4) within the period from Ja…

AdultMalemedicine.medical_specialtyPediatricsAdolescentInfluenza vaccineRate ratioIncidence of Narcolepsy in GermanyYoung AdultInfluenza A Virus H1N1 SubtypeAdjuvants ImmunologicPhysiology (medical)GermanyEpidemiologyInfluenza HumanmedicineHumansYoung adultChildNarcolepsyRetrospective Studiesbusiness.industryIncidence (epidemiology)IncidenceVaccinationInfant NewbornInfantRetrospective cohort studyGeneral Medicinemedicine.diseaseInfluenza VaccinesChild PreschoolObservational studyFemaleNeurology (clinical)SeasonsbusinessSleepNarcolepsy
researchProduct

Pandemic influenza A (H1N1) infection in pregnant and nonpregnant women in Spain (2009-2010)

2014

The present study aimed to compare the main features of infection with pandemic influenza A virus in pregnant and nonpregnant women admitted to hospitals in Spain during the first waves of the 2009-2010 influenza pandemic. This was a prospective (November 2009 to June 2010), multicenter observational study. All cases were women of reproductive age who had not been vaccinated against seasonal or pandemic influenza A. Influenza infection was confirmed by reverse transcription-polymerase chain reaction (RT-PCR). The sociodemographic and clinical data of all cases were reviewed. A total of 219 inpatients, including 49 pregnant women and 170 nonpregnant women, were enrolled in the study upon adm…

AdultMicrobiology (medical)medicine.medical_specialtyAdolescentmedicine.drug_classAntibioticsDonesReproductive ageInfluenzavirusVirusYoung AdultEmbarassadesInfluenza A Virus H1N1 SubtypePregnancyInternal medicineInfluenza HumanmedicineHumansInfluenza virusesWomenPregnancy Complications InfectiousPandemicsRespiratory distressbusiness.industryPregnant womenPandemic influenzaGeneral MedicineInfluenza pandemicInfectious DiseasesIncreased riskSpainCase-Control StudiesFemaleObservational studybusiness
researchProduct

Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections

2020

ABSTRACTIntroductionNoninvasive respiratory support (NRS) such as noninvasive ventilation (NIV) and high flow nasal therapy (HFNT) have been used in the treatment of acute hypoxemic respiratory failure (AHRF) related to the coronavirus disease (COVID-19) and other viral infections. However, there is a lack of consensus in favor of or against NRS use due to the risks of worsening hypoxemia, intubation delay, and aerosols environmental contamination associated with the use of these tools. We aimed to summarize the evidence on the use of NRS in adult patients with COVID-19 and other viral pneumonia (i.e. H1N1, SARS, MERS) and AHRF. We also searched for studies evaluating the risk of aerosoliza…

Adultmedicine.medical_specialtyContext (language use)Diseasemedicine.disease_causeHIGH FLOW NASAL THERAPYAirborne transmissionHFNCHypoxemialaw.invention03 medical and health sciences0302 clinical medicineInfluenza A Virus H1N1 SubtypeRandomized controlled trial030202 anesthesiologylawmedicineHumansCOVID-19; Noninvasive ventilation Pneumonia viral Adult Humans Pandemics SARS-CoV-2 COVID-19 Coronavirus. Influenza A Virus H1N1 Subtype Noninvasive Ventilation Respiratory InsufficiencyH1N1 SubtypeIntensive care medicinePandemicsAerosolizationCoronavirusNoninvasive VentilationPneumonia viralSARS-CoV-2business.industryCOVID-19030208 emergency & critical care medicinemedicine.diseaseCoronavirusAnesthesiology and Pain MedicineCoronavirus. Influenza A VirusViral pneumoniamedicine.symptomRespiratory InsufficiencybusinessHFNT
researchProduct

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Projec…

2004

To the Editor: Regarding the study by Megherbi et al1 performed to evaluate stroke features, prognosis, and functional outcome in patients with diabetes compared with patients without diabetes, we would like to discuss some issues of potential interest: First, the authors analyzed diabetic patients classified in accordance with WHO diagnostic criteria for diabetes used in 1993 (fasting plasma glucose >140 mg/dL), so it is probably an underestimation of the number of diabetic subjects in the 4537 consecutive patients with ischemic stroke enrolled. Perhaps if they could have classified diabetic patients in accordance with American Diabetes Association (1997)2 criteria (fasting plasma glucose …

Advanced and Specialized NursingAmerican diabetes associationmedicine.medical_specialtybusiness.industryStroke subtypemedicine.diseaseFight-or-flight responseNewly diagnosed diabetesInternal medicineDiabetes mellitusIschemic strokemedicineIn patientNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke
researchProduct

First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection

2010

A pandemic influenza A/H1N1v strain with the neuraminidase H274Y mutation was detected in nasal secretions of a 2-year-old leukemic patient with influenza-like illness after 18 days of treatment with oseltamivir. At baseline, no drug-resistant virus was found, while 4 days after treatment initiation a mix- ture of wild-type and mutated virus was detected. After treatment interruption, the wild type influenza virus re-emerged and became prevalent in nasal secretions after a few days, suggesting the lower fitness of the mutated virus strain. The patient slowly improved concurrently with a decrease in virus load, which resulted negative 42 days after diagnosis. No other drug-resistant influenz…

Bodily SecretionsvirusesResistanceDrug ResistanceSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causePandemic H1N1v Oseltamivir Resistancechemistry.chemical_compoundInfluenza A Virus H1N1 SubtypePandemicInfluenza A virusInfluenza A VirusViralChildViral LoadTreatment OutcomeInfectious DiseasesItalyChild PreschoolRNA ViralFemaleViral diseaseViral loadH1N1vSequence AnalysisH1N1v; Oseltamivir; Pandemic; Resistance; Amino Acid Substitution; Antiviral Agents; Bodily Secretions; Child Preschool; Female; Humans; Immunocompromised Host; Influenza A Virus H1N1 Subtype; Influenza Human; Italy; Molecular Sequence Data; Mutation Missense; Neuraminidase; Nose; Oseltamivir; RNA Viral; Sequence Analysis DNA; Treatment Outcome; Viral Load; Viral Proteins; Withholding Treatment; Drug Resistance Viral; Virology; Infectious DiseasesHumanOseltamivirMolecular Sequence DataMutation MissenseNeuraminidaseBiologyNoseAntiviral AgentsVirusresistanceImmunocompromised HostViral ProteinsOseltamivirVirologyDrug Resistance ViralInfluenza HumanmedicineHumansH1N1 SubtypePreschoolInfluenza-like illnessPandemicSequence Analysis DNADNAVirologyInfluenzaInfluenza; A/H1N1v; Oseltamivir; resistancechemistryAmino Acid SubstitutionWithholding TreatmentMutationbiology.proteinRNAA/H1N1vMissenseNeuraminidase
researchProduct

Plasma concentration following oral and intramuscular atropine in children and their clinical effects.

1997

In a paediatric population, we compared i.m. v oral atropine premedication to a control group without atropine and determined atropine plasma concentrations (APC). Forty-five children were randomly assigned to one of three groups. Group I received atropine, 20 micrograms.kg-1 i.m., 15 min prior to induction. Group II received atropine, 30 micrograms.kg-1 orally, group III received no atropine. APC (expressed as percent of muscarine-2 receptor subtype occupancy), heart rate, rectal temperature, and salivation were determined before atropine, and 15, 25, 45, 60, 90, 120 (no APC), and 150 min following atropine. Only 10-20% of the M2-cholinoceptors were occupied after oral atropine with a peak…

BradycardiaAtropineMalemedicine.medical_specialtyGroup iiAdministration OralMuscarinic AntagonistsInjections IntramuscularReceptor subtypeBody TemperatureHeart RateInternal medicineHeart rateMedicineHumansChildReceptor Muscarinic M2business.industryReceptors MuscarinicAtropineAnesthesiology and Pain MedicineEndocrinologyAnesthesiaChild PreschoolPediatrics Perinatology and Child HealthPlasma concentrationPremedicationFemalemedicine.symptombusinessSalivationPreanesthetic MedicationPaediatric populationmedicine.drugPaediatric anaesthesia
researchProduct

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

2014

Introduction More than 70 common alleles are known to be involved in breast cancer (BC) susceptibility, and several exhibit significant heterogeneity in their associations with different BC subtypes. Although there are differences in the association patterns between BRCA1 and BRCA2 mutation carriers and the general population for several loci, no study has comprehensively evaluated the associations of all known BC susceptibility alleles with risk of BC subtypes in BRCA1 and BRCA2 carriers. Methods We used data from 15,252 BRCA1 and 8,211 BRCA2 carriers to analyze the associations between approximately 200,000 genetic variants on the iCOGS array and risk of BC subtypes defined by estrogen re…

Cancer ResearchReceptor ErbB-2Genes BRCA2BRCALOCIGenes BRCA1MODIFIERSVARIANTSErbB-2610 Medical sciences MedicineDuctalReceptorsMedicine and Health SciencesINVESTIGATORSBreastskin and connective tissue diseasesProgesteroneMedicine(all)Carcinoma Ductal BreastMiddle AgedAdult; Aged; Alleles; Breast Neoplasms; Carcinoma; Carcinoma Ductal Breast; Carcinoma Lobular; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Receptor ErbB-2; Receptors Estrogen; Receptors Progesterone; Genes BRCA1; Genes BRCA2; Cancer Research; OncologyOncologyReceptors EstrogenTUMOR SUBTYPESFemaleReceptors ProgesteroneReceptorResearch ArticleAdultHeterozygote610Breast NeoplasmsMEDULLARY CARCINOMAOVARIAN-CANCERLobularHumansGenetic Predisposition to DiseaseGENOME-WIDE ASSOCIATIONAllelesAgedNeoplasm StagingAdult; Aged; Alleles; Breast Neoplasms; Carcinoma; Carcinoma Ductal Breast; Carcinoma Lobular; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Receptor ErbB-2; Receptors Estrogen; Receptors Progesterone; Genes BRCA1; Genes BRCA2CONSORTIUMCarcinomaBRCA1EstrogenBRCA2Carcinoma LobularESTROGEN-RECEPTORGenesNeoplasm GradingBreast Cancer Research
researchProduct

Corrigendum to: α-Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors (FEB…

2003

Corrigendum to: K-Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors (FEBS 27779) [FEBS Letters 554 (2003) 219^223]C Annette Nickea;1, Marek Samochockib, Marion L. Loughnana, Paramjit S. Bansala, Alfred Maelickeb, Richard J. Lewisa; aInstitute for Molecular Bioscience, University of Queensland, Brisbane, Qld. 4072, Australia bInstitute for Physiological Chemistry and Pathobiochemistry, University of Mainz, D-55099 Mainz, Germany First published online 24 December 2003

ChemistryBiophysicsSubtype selectivityCell BiologyPharmacologyBiochemistrylaw.inventionNicotinic agonistGanglion type nicotinic receptorStructural BiologylawPhysiological chemistryGeneticsRecombinant DNAAlpha-4 beta-2 nicotinic receptorMolecular BiologyAcetylcholine receptorα conotoxinFEBS Letters
researchProduct